Review Examines Cancer Therapy Heart Risks
A new review in Cardio-Oncology examines the rising cardiovascular mortality among cancer survivors and critiques current methods for assessing cardiotoxicity ...
A new review in Cardio-Oncology examines the rising cardiovascular mortality among cancer survivors and critiques current methods for assessing cardiotoxicity ...
A narrative review evaluates the dual vascular and immune-mediated cardiotoxicity profile of the bispecific antibody ivonescimab and proposes a risk-stratified ...
A retrospective registry study indicates that daratumumab-based therapy in the first two treatment lines is associated with improved survival and ...
A case report describes severe hypertriglyceridemia in a 50-year-old colorectal cancer patient with factor V Leiden thrombophilia during adjuvant capecitabine ...
A cross-sectional study of 97 long-term childhood cancer survivors exposed to anthracyclines found common cardiovascular risk factors and higher NT-proBNP ...
A retrospective cohort study of women with ER-positive breast cancer and cardiovascular risk factors found that aromatase inhibitor therapy was ...
A CMR study of 97 women with breast cancer found that aortic distensibility fell within three months of starting potentially ...
A review finds peripheral oedema and hypertension documented with daraxonrasib, but no published cardiac endpoint data at Phase 3 scale.
A meta-analysis of 23 studies reports a pooled atrial fibrillation prevalence of 8.5% among cancer patients treated with radiation therapy, ...
Adult survivors of high-risk childhood ALL treated with anthracyclines showed a shift over decades from dilated to restrictive-like cardiomyopathy, leaving ...
A UK Biobank study of more than 8,700 cancer survivors links several healthy dietary patterns to lower cardiovascular risk and ...
A survey of 74 patients with HER2-positive breast cancer in Australia and the United States found 74.3% were likely to ...
A new commentary in Cardio-Oncology marks 30 years since Daniela Cardinale coined the term cardio-oncology and presents the first English ...
A mouse study identifies the mitochondrial enzyme CMPK2 as a key mediator of doxorubicin heart injury and reports that flavin ...
A case report details the diagnostic and therapeutic challenges of managing immune checkpoint inhibitor myocarditis in a patient with coexisting ...
Heart muscle cells grown from lung cancer patients reproduce individual susceptibility to osimertinib-induced cardiac dysfunction, with impaired AMPK–LKB1 signaling marking ...
A German multicentre survey of 120 hospital physicians finds wide disagreement among cardiologists and internists on LVEF thresholds, strain imaging ...
A real-world cohort study of 114 patients found that 38.6 percent developed at least one cardiovascular complication during Bruton's tyrosine ...
A new review in Cardio-Oncology outlines how nanoparticle drug delivery systems could reduce doxorubicin-induced cardiotoxicity while preserving antitumor efficacy.
Researchers in Singapore propose a multidisciplinary institutional protocol for diagnosing and treating rare primary cardiac sarcomas, illustrated by two left ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.